摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(biphenyl-4-ylmethyl)-2-methyl-1,8-naphthyridine-3-carboxamide | 1241909-54-5

中文名称
——
中文别名
——
英文名称
N-(biphenyl-4-ylmethyl)-2-methyl-1,8-naphthyridine-3-carboxamide
英文别名
2-methyl-N-[(4-phenylphenyl)methyl]-1,8-naphthyridine-3-carboxamide
N-(biphenyl-4-ylmethyl)-2-methyl-1,8-naphthyridine-3-carboxamide化学式
CAS
1241909-54-5
化学式
C23H19N3O
mdl
——
分子量
353.423
InChiKey
KUFZAODTKBIQFK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    27
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    54.9
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE
    申请人:MITSUBISHI CHEMICAL CORPORATION
    公开号:US20200317706A1
    公开(公告)日:2020-10-08
    Provided is an iridium complex compound represented by formula (1) below. [Ir is an iridium atom. C 1 to C 6 are carbon atoms. N 1 and N 2 are nitrogen atoms. R 1 to R 4 are each a hydrogen atom or a substituent. a to d are maximum integer numbers of possible substituents on rings Cy 1 to Cy 4 , respectively. m and n are each 1 or 2, and m+n=3. The ring Cy 1 is represented by formula (2) or (2′) below. The ring Cy 3 is an aromatic or heteroaromatic ring including the carbon atoms C 4 and C 5 . The ring Cy 4 is a heteroaromatic ring including the carbon atom C 6 and the nitrogen atom N 2 .]
    提供的配合物化合物的化学式如下所示。 [Ir 代表原子。C1到C6代表碳原子。N1和N2代表氮原子。R1到R4分别代表氢原子或取代基。a到d分别代表环Cy1到Cy4上可能的取代基的最大整数个数。m和n分别为1或2,且m+n=3。环Cy1的化学式如下所示。环Cy3是包括碳原子C4和C5的芳香或杂芳环。环Cy4是包括碳原子C6和氮原子N2的杂芳环。]
  • NOVEL BRONCHODILATING DIAZAHETEROARYLS
    申请人:Johansson Martin
    公开号:US20120040942A1
    公开(公告)日:2012-02-16
    The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.
    这项发明涉及具有通式(I)的新化合物,这些化合物可用于治疗由支气管痉挛引起的疾病或疾病,例如慢性阻塞性肺疾病(COPD)和哮喘。
  • [EN] ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME<br/>[FR] COMPOSÉ IMIDATE À INSATURATION ?, ? ET COMPOSITION PESTICIDE LE CONTENANT
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2009064031A1
    公开(公告)日:2009-05-22
    There is provided a compound having an excellent controlling effect on pests, represented by the formula (I): wherein, A and E independently represent a -R1 group, a -L1-R1 group, etc.; G represents a -L2-R1 group, a -S(O)2-R4 group, etc.; X represents a -S-R5 group or a -O-R6 group; Z represents an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; R1 represents an optionally substituted C1-C20 chain hydrocarbon group, etc.; R5 represents a substituted C1-C4 alkyl group, an optionally substituted C5-C10 alkyl group, etc.; R6 represents a substituted C1-C2 alkyl group, an optionally substituted C3-C10 alkyl group, etc.; L1 represents a an oxygen atom, a sulfur atom, a -S(O)- group, or a -S(O)2- group; and L2 represents an oxygen atom or a sulfur atom.
    提供一种在害虫上具有优异控制效果的化合物,其表示为以下结构式(I):其中,A和E分别代表一个-R1基团,一个-L1-R1基团等;G代表一个-L2-R1基团,一个-S(O)2-R4基团等;X代表一个-S-R5基团或一个-O-R6基团;Z代表一个可选择取代的碳环基团或一个可选择取代的杂环基团;R1代表一个可选择取代的C1-C20链烃基团等;R5代表一个取代的C1-C4烷基基团,一个可选择取代的C5-C10烷基基团等;R6代表一个取代的C1-C2烷基基团,一个可选择取代的C3-C10烷基基团等;L1代表一个氧原子,一个原子,一个-S(O)-基团,或一个-S(O)2-基团;L2代表一个氧原子或一个原子。
  • [EN] (+)-TRANS-ISOMERS OF (1-PHOSPHONOMETHOXY-2-ALKYLCYCLOPROPYL) METHYL NUCLEOSIDE DERIVATIVES, PROCESS FOR THE PREPARATION OF STEREOISOMERS THEREOF, AND USE OF ANTIVIRAL AGENTS THEREOF<br/>[FR] TRANS-ISOMERES (+) DE DERIVES DE NUCLEOSIDE ( 1-PHOSPHONOMETHOXY-2-ALKYLCYCLOPROPYL)METHYLE, PROCESSUS DE PREPARATION DE STEREO-ISOMERES DE CEUX-CI ET UTILISATION D'AGENTS ANTIVIRAUX A BASE CEUX-CI
    申请人:LG LIFE SCIENCES LTD
    公开号:WO2004029064A1
    公开(公告)日:2004-04-08
    The present invention relates to (+)-trans-isomers of (1-phosphonomethoxy-2- alkylcyclopropyl)methyl nucleoside derivatives of the formula (1) which are useful as an antiviral agent (particularly, against hepatitis B virus), pharmaceutically acceptable saltss, hydrates, or solvates thereof, and processes for the preparation of stereoisomers of the compounds of the formula (1), and a composition for the treatment of viral diseases (particularly, against hepatitis B virus) comprising (+)-trans-isomer of the compound of the formula (1), pharmaceutically acceptable salt, hydrate, or solvate thereof as an active substance.
    本发明涉及公式(1)的(+)-反式异构体(1-磷酸甲氧基-2-烷基环丙基)甲基核苷衍生物,该衍生物可用作抗病毒剂(特别是对乙型肝炎病毒),其药用盐、合物或溶剂化合物,以及用于制备公式(1)化合物的立体异构体的方法,以及一种用于治疗病毒性疾病(特别是对乙型肝炎病毒)的组合物,包括公式(1)化合物的(+)-反式异构体,其药用盐、合物或溶剂化合物作为活性物质。
  • POLYDENTATE LIGAND METAL COMPLEX
    申请人:Kuramochi Yusuke
    公开号:US20120211706A1
    公开(公告)日:2012-08-23
    The present invention provides a metal complex that has excellent durability, and a device and the like having excellent durability that uses such a metal complex. Specifically, the present invention provides a metal complex comprising (a) a polydentate ligand having denticity of five or more that includes a heteroaromatic ring which contains two or more atoms selected from the group consisting of a nitrogen atom, an oxygen atom, and a sulfur atom, and (b) an ion of a metal selected from the group consisting of cerium, praseodymium, ytterbium, and lutetium; a composition comprising the metal complex and a charge transport material; an organic thin film obtained by using the metal complex or composition; and a device obtained by using the metal complex, composition, or organic thin film.
    本发明提供了一种具有优异耐久性的属配合物,以及使用这种属配合物的具有优异耐久性的设备等。具体地,本发明提供了一种属配合物,包括(a)具有五个或更多配位位点的多齿配体,其中包括一个含有来自氮原子、氧原子和原子的组成的两个或更多原子的杂环芳香环,以及(b)来自属的离子;包括所述属配合物和电荷传输材料的组合物;通过使用属配合物或组合物获得的有机薄膜;以及通过使用属配合物、组合物或有机薄膜获得的设备。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫